Viewing Study NCT02249234


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-03-03 @ 12:22 AM
Study NCT ID: NCT02249234
Status: COMPLETED
Last Update Posted: 2019-03-11
First Post: 2014-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain
Sponsor: Mount Sinai Hospital, Canada
Organization:

Study Overview

Official Title: Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ROBOT
Brief Summary: There are no previous reports on the use of OnabotulinumtoxinA (Botox) to treat men with scrotal pain that we found published.

We proposed a pilot study using Botox to block the nerves on a small group of men with chronic scrotal pain (CSP) who have failed the standard medical therapy. The men must have had temporary relief from a testicular cord block using local anaesthetic drug.

The encourage results of the pilot study has given us the background information to proceed with a formal randomised control trial of Botox vs placebo.

We hypothesized that Botox injections to block the testicular nerve will be effective in providing long term pain relief for men with scrotal pain.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: